The Burden of Alzheimer’s Disease Mortality in the United States, 1999-2018

Abstract

Background: The increasing prevalence of Alzheimer’s disease (AD), along with the associated burden on healthcare systems, presents a substantial public health challenge. Objective: This study aimed to investigate trends in AD mortality and the relevant burden across the United States (U.S.) from 1999 to 2018 and to predict mortality trends between 2019 and 2023. Methods: Data on AD-related deaths between 1999 and 2018 were collected from the WONDER database administered by the U.S. Centers for Disease Control and Prevention (CDC). The Joinpoint Regression Program was used to analyze mortality trends due to AD. Years of life lost (YLL) were calculated to explore the burden of AD deaths. An autoregressive integrated moving average (ARIMA) model was employed to forecast mortality trends from 2019 to 2023. Results: Over a recent 20-year period, the number of AD deaths in the U.S. increased from 44,536 (31,145 females and 13,391 males) to 122,019 (84,062 females and 37,957 males). The overall age-adjusted mortality rate increased from 16.5/100,000 in 1999 to 30.5/100,000 in 2018. AD mortality is projected to reach 42.40/100000 within the year 2023. Overall, AD resulted in 322,773.00 YLL (2.33 per 1000 population) in 1999 and 658,501.87 YLL (3.68 per 1000 population) in 2018. Conclusion: Our findings demonstrate an increase in AD mortality in the U.S. from 1999 to 2018 as well as a rapid increase from 2019 to 2023. The high burden of AD deaths emphasizes the need for targeted prevention, early diagnosis, and hierarchical management.

Trend dynamics of gout prevalence among the Chinese population, 1990-2019: A joinpoint and age-period-cohort analysis

“…The autocorrelation function (ACF) and the partial autocorrelation function (PACF) were then plotted to check the stationary of the sequence after differencing, and auto.arima() was used to establish the optimal model according to the Akaike information criterion (AIC) value. The auto.arima() function is suitable for different ARIMA models of univariate time series data, searches the models according to the provided constraint order, and determines the optimal model ( 27 , 28 ). The normality of model residuals was tested through QQ plots, ACF and PACF plots.…”

Recent Advances in Progresses and Prospects of IL-37 in Central Nervous System Diseases

“…Alzheimer’s disease (AD) is a neurodegenerative disease highly correlated with age [ 59 ]. From 1999 to 2018, the number of deaths from AD in the United States increased [ 60 ]. Currently, an estimated 6.2 million Americans 65 years of age and older have AD, and if no effective treatment is found, this number will continue to increase [ 61 ].…”

Predicting Diabetes and Estimating Its Economic Burden in China Using Autoregressive Integrated Moving Average Model

“…For example, with data on prostate cancer in Australia from 1982 to 2013, ARIMA model was used to predict the incidence of prostate cancer from 2014 to 2022 [ 9 ]. The ARIMA model was used to predict Alzheimer’s disease mortality in the United States from 2019 to 2023 [ 10 ]. In addition, ARIMA model has a wide range of applications in fields such as meteorology [ 11 ], economics [ 12 ] and agriculture [ 13 ].…”